G Bradley Cole

CIK 1337798 · General Manager - Diagnostics · last filed 2026-07-31

G Bradley Cole is a General Manager - Diagnostics who has filed 156 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for KNSA, was dated Jul 31, 2026. Across all open-market trades the lifetime net is −$33.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.1M across reported positions. 6 SEC filings were submitted jointly with EXACT SCIENCES CORP.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$2.06M

Companies

4

Total Filings

156

Lifetime Open-Market Net

-$33.74M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

Filer Profile

Reported Address

301 PENOBSCOT DRIVE
REDWOOD CITY, CA 94063

Related Filers

EXACT SCIENCES CORP — 6 joint filings, latest 2020-02-21

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
KNSA	Director	11,672	$75.79	$884.6K	-$299.1K	9	2026-07-31
CSTL	Director	32,976	$35.56	$1.17M	-$210.7K	12	2026-06-01
EXACT SCIENCES CORP (EXAS) Delisted	General Manager - Diagnostics	49,884	$104.91	$5.23M	-$5.89M	4	2020-02-21
GENOMIC HEALTH INC (GHDX) Delisted	CFO	84,342	—	—	-$27.34M	128	2019-10-09

Recent Filings

156 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2026-07-31	KNSA	Mixed	−8,173	-$299.1K	EDGAR
2026-07-29	KNSA	Notice (144)	−3,673	-$299.1K	EDGAR
2026-06-02	KNSA	Mixed	+2,799	$0	EDGAR
2026-06-01	CSTL	Grant (A)	—	$0	EDGAR
2026-05-27	CSTL	Exer (M)	+13,667	$0	EDGAR
2026-03-09	CSTL	Mixed	−2,655	-$194.7K	EDGAR
2026-03-05	CSTL	Notice (144)	−7,403	-$210.7K	EDGAR
2025-06-05	KNSA	Mixed	+3,173	$0	EDGAR
2025-05-23	CSTL	Mixed	+8,673	$0	EDGAR
2024-06-07	KNSA	Mixed	+4,373	$0	EDGAR

Showing 1–10 of 156

Page 1 of 16 Next

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.